Alok Singh

Title: Alok Singh: Innovator in Cancer Therapeutics

Introduction

Alok Singh is a prominent inventor based in Baltimore, MD (US), known for his significant contributions to cancer therapeutics. His innovative work focuses on developing methods to enhance the immune response against tumors, particularly through the modulation of myeloid-derived suppressor cells and other immune components.

Latest Patents

Alok Singh holds a patent for "Recombinant therapeutic interventions for cancer." This patent describes methods for suppressing the expression of myeloid-derived suppressor cells (MDSCs), M2 macrophages, and Treg cells in tumors. It also details the induction of macrophages, dendritic cells (DCs), and T effector cells in a tumor within a subject. The pharmaceutical composition includes a strain with an expression vector that is administered to the subject, showcasing a novel approach to cancer treatment. He has 1 patent to his name.

Career Highlights

Alok Singh is affiliated with Johns Hopkins University, where he conducts research and develops innovative therapeutic strategies. His work is instrumental in advancing the understanding of cancer biology and improving treatment options for patients.

Collaborations

Some of his notable coworkers include William R Bishai and Trinity J Bivalacqua, who collaborate with him on various research projects aimed at enhancing cancer therapies.

Conclusion

Alok Singh's contributions to cancer therapeutics through his innovative patent and research at Johns Hopkins University highlight his role as a key figure in the fight against cancer. His work continues to inspire advancements in the field of oncology.